Sales rise 21.72% to Rs 339.24 crore
Net profit of Caplin Point Laboratories rose 19.12% to Rs 79.06 crore in the quarter ended March 2022 as against Rs 66.37 crore during the previous quarter ended March 2021. Sales rose 21.72% to Rs 339.24 crore in the quarter ended March 2022 as against Rs 278.71 crore during the previous quarter ended March 2021.For the full year,net profit rose 23.76% to Rs 299.84 crore in the year ended March 2022 as against Rs 242.28 crore during the previous year ended March 2021. Sales rose 19.61% to Rs 1269.41 crore in the year ended March 2022 as against Rs 1061.29 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales339.24278.71 22 1269.411061.29 20 OPM %29.4630.75 -31.0930.97 - PBDT111.3794.83 17 432.72350.59 23 PBT99.9284.97 18 385.82313.62 23 NP79.0666.37 19 299.84242.28 24
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
